Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLS | O94925 | 5/20 | 0.48 |
| ▸ | CTSS | P25774 | 7/20 | 0.41 |
| ▸ | CTSK | P43235 | 5/20 | 0.41 |
| ▸ | CTSB | P07858 | 3/20 | 0.41 |
| ▸ | BRD4 | O60885 | 3/20 | 0.41 |
| ▸ | NAMPT | P43490 | 2/20 | 0.41 |
| ▸ | CTSL | P07711 | 2/20 | 0.41 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.41 |
| ▸ | KDM4A | O75164 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8579767 | 0.90 | NAMPT (0.46) | CTSSCTSKNAMPT | |
| SCHEMBL8579008 | 0.89 | AURKA (0.46) | GLSCTSSCTSKCTSBBRD4 | |
| SCHEMBL6187053 | 0.89 | BRD4 (0.45) | GLSCTSSCTSKCTSBBRD4 | |
| SCHEMBL8605367 | 0.86 | KCNA5 (0.43) | CTSSCTSKCTSBNAMPTCTSL | |
| SCHEMBL6186560 | 0.82 | NAMPT (0.52) | NAMPT | |
| SCHEMBL24087990 | 0.80 | GLS (0.51) | GLSCTSSCTSKCTSBBRD4 | |
| SCHEMBL16181822 | 0.80 | GLS (0.55) | GLSCTSSCTSKCTSBBRD4 | |
| SCHEMBL352314 | 0.78 | ERCC1 (0.52) | GLSCTSSCTSKCTSBBRD4 | |
| SCHEMBL6187094 | 0.77 | TDP1 (0.44) | CTSSCTSKCTSBCTSLIDO1 | |
| SCHEMBL1165088 | 0.77 | GLS (0.55) | GLSBRD4NAMPTCREBBPKDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998014449-A1 | FUSED PYRAZOLE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | NOVARTIS AG (CH) | 1998-04-09 | — | — | WO | disclosed |